Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02932501 · ClinicalTrials.gov registry record
Medication-related Osteonecrosis of the Jaw (MRONJ) Registry
A clinical trial of Bisphosphonate-Associated Osteonecrosis of the Jaw and Medication-related Osteonecrosis of the Jaw, sponsored by AO Clinical Investigation and Publishing Documentation.
- Active
- Registry status
- 518
- Enrollment target
- 14
- Study locations
NCT02932501 is a study of Bisphosphonate-Associated Osteonecrosis of the Jaw and Medication-related Osteonecrosis of the Jaw that is active but no longer recruiting, run by AO Clinical Investigation and Publishing Documentation. The registered enrollment target is 518 participants. The trial reports 14 study locations across 2 states.
The verdict
NCT02932501, a study of Bisphosphonate-Associated Osteonecrosis of the Jaw and Medication-related Osteonecrosis of the Jaw, is active but no longer recruiting, sponsored by AO Clinical Investigation and Publishing Documentation.
- ACTIVE NOT RECRUITING
- Registry status
- 518 participants
- Enrollment target
- 14
- Study locations
Study Summary
Approximately 500 patients will be included in this patient registry. Data collection includes demographics, clinical data of underlying disease and use of bisphosphonates, denosumab and antiangiogenic drugs , degree and extension of osteonecrosis, osteonecrosis-specific treatment, outcomes and complications within 1 year after treatment.
Conditions Studied
Interventions
- PROCEDURE Surgical treatment
- PROCEDURE Conservative treatment
- PROCEDURE Adjuvant non-surgical treatment
Study Locations (14)
Other
- Helsinki University Hospital - Helsinki
- Charité - Universitätsmedizin Berlin - Berlin
- Universitätskliniken Eppendorf - Hamburg
- Ludwig-Maximilians University Munich, Klinik und Poliklinik für Mund-, Kiefer und Gesichtschirurgie - München
- Eramus MC - Rotterdam
- Hamad Medical Corporation - Doha
- Emergency Clinical County Hospital of Constanta - Constanța
- University Medical Centre Ljubljana - Ljubljana
- Kyungpool National University - Daegu
- 12 de Octubre University Hospital - Madrid
- Universitätsspital Basel - Basel
- Luzerner Kantonsspital - Lucerne
- Universitätsspital Zürich - Zurich
Kentucky
- University of Kentucky Chandler Medical Center - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 518 participants |
| Start Date | 2017-08-14 |
| Est. Completion | 2024-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02932501
The ClinicalTrials.gov registry entry for NCT02932501 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 518 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AO Clinical Investigation and Publishing Documentation, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Bisphosphonate-Associated Osteonecrosis of the Jaw appearing as the primary indexed condition, and to 3 interventions - of which Surgical treatment is the first listed.
NCT02932501 reports 14 study locations spanning 2 distinct geographic areas - top geographies include Other, Kentucky.
Frequently Asked Questions
What is clinical trial NCT02932501 about?
NCT02932501 is a clinical study titled "Medication-related Osteonecrosis of the Jaw (MRONJ) Registry". Approximately 500 patients will be included in this patient registry. Data collection includes demographics, clinical data of underlying disease and use of bisphosphonates, denosumab and antiangiogenic drugs , degree and extension of osteonecrosis, osteonecrosis-specific treatment, outcomes and comp...
What is the current status of trial NCT02932501?
This trial is currently active not recruiting. The enrollment target is 518 participants. The study started on 2017-08-14. Estimated completion is 2024-04.
What conditions does trial NCT02932501 study?
This clinical trial studies the following conditions: Bisphosphonate-Associated Osteonecrosis of the Jaw, Medication-related Osteonecrosis of the Jaw.
What interventions are being tested in trial NCT02932501?
The interventions under investigation include: Surgical treatment (PROCEDURE), Conservative treatment (PROCEDURE), Adjuvant non-surgical treatment (PROCEDURE).
Who is sponsoring clinical trial NCT02932501?
This trial is sponsored by AO Clinical Investigation and Publishing Documentation, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02932501 being conducted?
This trial has 14 study locations across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bisphosphonate-Associated Osteonecrosis of the Jaw
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Bisphosphonate-Associated Osteonecrosis of the Jaw
All registered trials for this condition
Medication-related Osteonecrosis of the Jaw
All registered trials for this condition
Kentucky
All trials with a study site in Kentucky
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.